Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar pre92lude (< 20) Submitted: 3/9/2010 8:05:31 PM : Outperform Start Price: $21.68 MYL Score: -15.61

people buy generics...

Featured Broker Partners


Advertisement